CITADEL ADVISORS LLC

Holdings History for Neurogene Inc. - Common Stock, $0.000001 par value (NGNE)

Symbol: NGNE on Nasdaq
Investment type: Equity / Common Stock, $0.000001 par value

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		0.01%	+0.01%	$7,503,097	364,228	+364,228	NEW	$20.60	Q4 2025
30 Jun 2025			-0%	$0	0	-16,416	-100%	$17.62	Q2 2025
30 Jun 2025	call		-0%	$0	0	-40,600	-100%	$17.62	Q2 2025
30 Jun 2025	put		-0%	$0	0	-10,000	-100%	$17.62	Q2 2025
31 Mar 2025		0%	+0%	$192,231	16,416	+16,416	NEW	$11.71	Q1 2025
31 Mar 2025	call	0%	+0%	$475,426	40,600	+9,400		$11.71	Q1 2025
31 Mar 2025	put	0%	-0%	$117,100	10,000	-28,500		$11.71	Q1 2025
31 Dec 2024	call	0%	+0%	$713,232	31,200	+31,200	NEW	$22.86	Q4 2024
31 Dec 2024	put	0%	+0%	$880,110	38,500	+38,500	NEW	$22.86	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.